326 related articles for article (PubMed ID: 6290198)
21. Corticotropin-releasing factor stimulates accumulation of adenosine 3', 5'-monophosphate in rat pituitary corticotrophs.
Labrie F; Veilleux R; Lefevre G; Coy DH; Sueiras-Diaz J; Schally AV
Science; 1982 May; 216(4549):1007-8. PubMed ID: 6281886
[TBL] [Abstract][Full Text] [Related]
22. The role of cyclic AMP in CRF-induced ACTH secretion.
Portanova R; Brattin WJ
Proc Soc Exp Biol Med; 1978 Oct; 159(1):6-11. PubMed ID: 213783
[No Abstract] [Full Text] [Related]
23. Interactions between CRF, epinephrine, vasopressin and glucocorticoids in the control of ACTH secretion.
Labrie F; Giguere V; Proulx L; Lefevre G
J Steroid Biochem; 1984 Jan; 20(1):153-60. PubMed ID: 6323861
[TBL] [Abstract][Full Text] [Related]
24. The intestinal peptide PHI-27 potentiates the action of corticotropin-releasing factor on ACTH release from rat pituitary fragments in vitro.
Tilders F; Tatemoto K; Berkenbosch F
Endocrinology; 1984 Oct; 115(4):1633-5. PubMed ID: 6090109
[TBL] [Abstract][Full Text] [Related]
25. Adrenocorticotropin and beta-endorphin release from rat adenohypophysis in vitro: inhibition by prostaglandin E2 formed locally in response to vasopressin and corticotropin-releasing factor.
Vlaskovska M; Hertting G; Knepel W
Endocrinology; 1984 Sep; 115(3):895-903. PubMed ID: 6204854
[TBL] [Abstract][Full Text] [Related]
26. Posttranslational modulation of glucocorticoid feedback inhibition at the pituitary level.
Lim MC; Shipston MJ; Antoni FA
Endocrinology; 2002 Oct; 143(10):3796-801. PubMed ID: 12239090
[TBL] [Abstract][Full Text] [Related]
27. Desensitization of corticotropin-releasing factor receptors.
Reisine T; Hoffman A
Biochem Biophys Res Commun; 1983 Mar; 111(3):919-25. PubMed ID: 6301492
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of protein kinase C activity in cultured pituitary cells attenuates both cyclic AMP-independent and -dependent secretion of ACTH.
Koch B; Lutz-Bucher B
Mol Cell Endocrinol; 1991 May; 77(1-3):57-65. PubMed ID: 1667763
[TBL] [Abstract][Full Text] [Related]
29. Specific receptors for vasopressin in the pituitary gland: evidence for down-regulation and desensitization to adrenocorticotropin-releasing factors.
Koch B; Lutz-Bucher B
Endocrinology; 1985 Feb; 116(2):671-6. PubMed ID: 2981673
[TBL] [Abstract][Full Text] [Related]
30. Additive effects of epinephrine and corticotropin-releasing factor (CRF) on adrenocorticotropin release in rat anterior pituitary cells.
Giguère V; Labrie F
Biochem Biophys Res Commun; 1983 Jan; 110(2):456-62. PubMed ID: 6301454
[TBL] [Abstract][Full Text] [Related]
31. Effects of corticotrophin-releasing factor and arginine-vasopressin on proopiomelanocortin (POMC) mRNA levels, release and storage of adrenocorticotrophin from mouse anterior pituitary cells.
Castro MG
Comp Biochem Physiol Comp Physiol; 1993 Jan; 104(1):105-12. PubMed ID: 8094652
[TBL] [Abstract][Full Text] [Related]
32. Tumor necrosis factor alpha inhibits the hormonal response of the pituitary gland to hypothalamic releasing factors.
Gaillard RC; Turnill D; Sappino P; Muller AF
Endocrinology; 1990 Jul; 127(1):101-6. PubMed ID: 2163305
[TBL] [Abstract][Full Text] [Related]
33. Vasopressin and angiotensin induce inositol lipid breakdown in rat adenohypophysial cells in primary culture.
Guillon G; Gaillard RC; Kehrer P; Schoenenberg P; Muller AF; Jard S
Regul Pept; 1987 Aug; 18(3-4):119-29. PubMed ID: 2823320
[TBL] [Abstract][Full Text] [Related]
34. Adenylate-cyclase-dependent pituitary adrenocorticotropin secretion is defective in the inflammatory-disease-susceptible Lewis rat.
Bernardini R; Iurato MP; Chiarenza A; Lempereur L; Calogero AE; Sternberg EM
Neuroendocrinology; 1996 May; 63(5):468-74. PubMed ID: 8738585
[TBL] [Abstract][Full Text] [Related]
35. Synthetic corticoliberin needs arginine vasopressin for full corticotropin releasing activity.
Bény JL; Baertschi AJ
Experientia; 1982 Sep; 38(9):1078-9. PubMed ID: 6290259
[No Abstract] [Full Text] [Related]
36. ACTH secretion from isolated hypophysial anterior lobes of male and female newborn rats: effects of corticotrophin-releasing factor, arginine vasopressin and oxytocin alone or in combination.
Hary L; Dupouy JP; Chatelain A
J Endocrinol; 1993 Apr; 137(1):123-32. PubMed ID: 8388013
[TBL] [Abstract][Full Text] [Related]
37. Phorbol 12-myristate 13-acetate and vasopressin potentiate the effect of corticotropin-releasing factor on cyclic AMP production in rat anterior pituitary cells. Mechanisms of action.
Abou-Samra AB; Harwood JP; Manganiello VC; Catt KJ; Aguilera G
J Biol Chem; 1987 Jan; 262(3):1129-36. PubMed ID: 2433273
[TBL] [Abstract][Full Text] [Related]
38. Oxytocin as well as vasopressin potentiate ovine CRF in vitro.
Antoni FA; Holmes MC; Jones MT
Peptides; 1983; 4(4):411-5. PubMed ID: 6316291
[TBL] [Abstract][Full Text] [Related]
39. Calcium-dependent control of corticotropin release in rat anterior pituitary cell cultures.
Abou-Samra AB; Catt KJ; Aguilera G
Endocrinology; 1987 Sep; 121(3):965-71. PubMed ID: 2441983
[TBL] [Abstract][Full Text] [Related]
40. Effect of chronic secretagogue exposure on pro-adrenocorticotropin/endorphin production and secretion in primary cultures of rat anterior pituitary.
Wand GS; Eipper BA
Endocrinology; 1987 Mar; 120(3):953-61. PubMed ID: 3492370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
